Chalice Brands Ltd. Announces Resignation of Interim Chief Financial Officer
PORTLAND, Ore., Oct. 28, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF)…
Year: 2022
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022
NEW HAVEN, Conn., Oct. 28, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR Due to CRO Data Management Issues
Company to complete and submit responses to FDA clinical hold Continues to study leronlimab in…
Akari Therapeutics Announces Receipt of Nasdaq Minimum Bid Price Notification
NEW YORK and LONDON, Oct. 28, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
ARCA biopharma Announces Third Quarter 2022 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets,…
Enablence Technologies Inc. Announces Financial Results for Fiscal Year 2022
Ottawa, Ontario–(Newsfile Corp. – October 28, 2022) – Enablence Technologies Inc. (TSXV: ENA) (“Enablence” or…
Canuck Roofing Works Closely with Restoration and Insurance Companies to Get Residents Back into Their Homes After Damaging Natural Disasters
Canuck Roofing is teaming up with restoration and insurance companies to help repair, restore, and…
DEINOVE REQUESTS RECEIVERSHIP PROCEEDINGS
DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and exploitation…
Orion Corporation: Acquisition of Own Shares 28.10.2022
Orion Corporation NOTIFICATION 28.10.2022 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 28.10.2022 Date 28.10.2022…
HyperonChain, One of World’s Fastest Growing Blockchain with DeFi & Metaverse Ecosystem, Goes Live on TestNet
New York, New York–(Newsfile Corp. – October 28, 2022) – HyperonChain (HPN), one of the…
KwikClick, Inc. (KWIK) Announces Uplist to OTCQB Markets, Commences Trading Under the Symbol “KWIK”
Bountiful, Utah–(Newsfile Corp. – October 28, 2022) – KwikClick, Inc. (OTCQB: KWIK) (“the Company or…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Babcock & Wilcox Enterprises, Inc. (BW) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
GrainPro Announces Q3 2022 Results
WASHINGTON–(BUSINESS WIRE)–#FightWorldHunger–GrainPro Inc. announced today that its 2022 third quarter sales were $4.12 million, a…
Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Positioning for Global Acquisitions and Shareholder Update
ESTERO, Fla., Oct. 28, 2022 (GLOBE NEWSWIRE) — Marijuana Strategic Ventures, Inc. (the “Company”)(OTC: MSVI)…
Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DLBCL)
Media Release COPENHAGEN, Denmark; October 28, 2022 Genmab has Submitted Biologics License Application (BLA) to…
Correction: Software Effective Solutions Subsidiary MEDCANA (OTC: SFWJ) Announces Successful Launch of Test Greenhouses for Microclimates and Genetics with Colombia Partner Firms
MedCana’s initial focus is on partnering and developing companies in Latin America with an initial…
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 ISELIN, N.J., Oct….
SciSparc: Wellution™ Successfully Launched a New Keto Gummies Apple Cider Vinegar Product and Generated $100,000 In Revenues Within 30 Days
Since launch the new product has had approximately 117% ROI TEL AVIV, Israel, Oct. 28,…
Altimmune to Present Pemvidutide Clinical Data at the Upcoming AHA Scientific Sessions and AASLD The Liver Meeting®
GAITHERSBURG, Md., Oct. 28, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
Medicenna Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
TORONTO and HOUSTON, Oct. 28, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…